Infliximab induces remission of pyoderma gangrenosum.
Romero-Gómez
Manuel
M
Sánchez-Muñoz
Diego
D
D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D005260:Female; D005401:Fissure in Ano / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D005500:Follow-Up Studies; D006801:Humans; D000069285:Infliximab; D007262:Infusions, Intravenous; D017511:Pyoderma Gangrenosum / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D000069285:Infliximab